通过靶向肿瘤相关巨噬细胞的嵌合受体工程化溶瘤病毒重振内源性抗肿瘤免疫
Rejuvenating endogenous antitumor immunity via a chimeric receptor-engineered oncolytic virus targeting tumor-associated macrophages.
我们的研究结果定义了一个精准溶瘤平台,该平台能够解除TAM介导的免疫抑制,同时增强适应性免疫,为癌症免疫治疗提供了一条有前景的转化途径。
英文原题:Immunotherapy for Cancer: Current Advances and Future Directions.
Immunotherapy for Cancer: Current Advances and Future Directions.
免疫治疗为多种癌症的治疗带来了根本性转变,为癌症患者带来了希望。
免疫治疗为多种癌症的治疗带来了根本性转变,为癌症患者带来了希望。与传统疗法不同,它利用患者自身的免疫系统来精确识别并摧毁癌细胞。免疫治疗的发展历程非凡,彻底改变了肿瘤学,并为现代免疫疗法的开发铺平了道路。免疫治疗采用了多种方法,包括免疫检查点抑制剂、过继性细胞疗法、癌症疫苗、肿瘤微环境重编程、单克隆抗体、细胞因子疗法、溶瘤病毒疗法以及联合策略。多种免疫疗法正被用于不同类型的癌症,如皮肤癌、肺癌、膀胱癌、肾癌、肝癌、乳腺癌和血液系统癌症。尽管免疫疗法提供了有效的癌症治疗手段,但在临床实施中仍面临一些挑战。为克服这些局限性,未来方向着重于开发个性化及联合疗法、引入 AI 以及良好的递送系统。本综述的主要目的是概述免疫治疗在癌症治疗中的演变历程、不同方法、局限性、进展及未来发展。
Immunotherapy delivers a fundamental shift in the treatment of multiple cancers, offering hope for patients with cancer. Unlike conventional therapies, it leverages the patient's immune system to precisely identify and destroy cancer cells. The remarkable journey of immunotherapy's has revolutionized oncology and paved the way for the development of modern immunotherapies. Several approaches are applied for immunotherapy, including immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, tumor microenvironment reprogramming, monoclonal antibodies, cytokine therapies, oncolytic virus therapy and combination strategies. Various immunotherapies are being used for different types of cancers like skin, lung, bladder, kidney, liver, breast and blood cancers. Despite providing an effective cancer treatment, immunotherapies face some challenges in their clinical implementation. To overcome these limitations, future directions emphasize the development of personalized and combination therapies, the incorporation of AI and a good delivery system. The main aim of this review is to give an overview of the journey of evolution, different approaches, limitations, advances and future development for immunotherapy in cancer treatment.
MEMBER ACCOUNT
登录成功会直接打开下一页。